Author

I. Pallavicini

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Research Focus:differential expression· 1

Frequent Co-Authors

S. Minucci· 3 shared R. Ravasio· 2 shared A. Di Martino· 1 shared A. O. Bigogno· 1 shared B. Duso· 1 shared C. B. Nava Lauson· 1 shared C. Gentile· 1 shared C. Steinkuhler· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

S. Minucci

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

LSD1 inhibition improves efficacy of adoptive T cell therapy by enhancing CD8+ T cell responsiveness.

I. Pallavicini, T. M. Frasconi, E. Ceccaci, S. Tiberti, C. B. Nava Lauson, E. Preto, A. O. Bigogno, M. Mangione, E. Sala, M. Iannacone, M. Kuka, L. Nezi, S. Minucci, T. Manzo

This study shows that inhibiting LSD1 enhances CD8+ T cell function in adoptive T cell therapy, leading to improved antitumor immunity and synergistic effects with anti-PDL1 therapy.

bioRxiv · Oct 27, 2023Immunology

Inhibiting LSD1 suppresses coronavirus-induced inflammation but spares innate antiviral activity

L. Mazzarella, F. Santoro, R. Ravasio, P. Massa, S. Rodighiero, E. Gaviln, M. Romanenghi, B. Duso, E. Bonetti, R. Pallavi, D. Trastulli, I. Pallavicini, C. Gentile, T. Leonardi, G. Buttinelli, , P. G. Pelicci

The paper shows inhibiting LSD1 reduces coronavirus-induced inflammation while preserving innate antiviral activity in macrophages.

bioRxiv · May 2, 2021 · PreprintImmunology

Pharmacological inhibition of LSD1 triggers myeloid differentiation by targeting GSE1, a novel oncogene in AML

L. Nicosia, F. L. Boffo, E. Ceccacci, I. Pallavicini, F. Bedin, E. Massignani, R. Ravasio, S. Minucci, T. Bonaldi

This study shows that LSD1 inhibitors induce AML cell differentiation by reducing GSE1, a novel oncogene, through transcriptional activation of immune response genes.

bioRxiv · Feb 16, 2021 · PreprintCancer Biology